Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. | J Med Genet | 2025 | 41159931 | PubTator, text mining | PubMed |
| Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2025 | 41070818 | PubTator, text mining | PubMed |
| Evaluation of risk-reducing radical fimbriectomy followed by delayed oophorectomy in high-risk Women: A single-center retrospective study. | Eur J Surg Oncol | 2025 | 41032970 | PubTator, text mining | PubMed |
| Homologous Recombination Proficiency in High-Grade Serous Epithelial Ovarian Cancer Tumors: The Dark Side of the Moon. | Curr Issues Mol Biol | 2025 | 41020824 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Rare Genetic Variants in Saudi COVID-19 Patients with Extreme Phenotypes. | Viruses | 2025 | 41012626 | PubTator, text mining | PubMed |
| Physicians' Controversies Towards Fertility Preservation in Young Patients with Gynecological Cancer: An MITO Survey. | Curr Oncol | 2025 | 41002597 | PubTator, text mining | PubMed |
| Prevalence of MUTYH Monoallelic Variants in Patients With Hereditary Cancer Using Multigene Panel Testing. | Cancer Med | 2025 | 41001951 | PubTator, text mining | PubMed |
Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review - an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need. | Acta Oncol | 2025 | 40988318 | PubTator, text mining | PubMed |
| Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types. | Cancer Res Commun | 2025 | 40981433 | PubTator, text mining | PubMed |
| Olaparib maintenance therapy for recurrent adult granulosa cell tumors: A case report. | J Obstet Gynaecol Res | 2025 | 40974087 | PubTator, text mining | PubMed |
| Head and Neck Cancer in Fanconi Anemia: Clinical Challenges and Molecular Insights into a DNA Repair Disorder. | Cancers (Basel) | 2025 | 40970532 | PubTator, text mining | PubMed |
| Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer. | JAMA Netw Open | 2025 | 40956577 | PubTator, text mining | PubMed |
| Cancer of the ovary, fallopian tube, and peritoneum: 2025 update. | Int J Gynaecol Obstet | 2025 | 40908761 | PubTator, text mining | PubMed |
| BRCA1 Exon 11 Mutations in Breast Cancer: A Study From Pakistan. | Genet Res (Camb) | 2025 | 40904409 | PubTator, text mining | PubMed |
| Selumetinib Treatment in a Neurofibromatosis Type 1 Child With Second Hit Mutation on the NF1 Gene. | Int J Dev Neurosci | 2025 | 40891287 | PubTator, text mining | PubMed |
Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study. | Cancer Rep (Hoboken) | 2025 | 40891252 | PubTator, text mining | PubMed |
| Clinicopathological features of Chinese ovarian cancer patients with double heterozygosity for cancer-predisposed genes. | BMC Cancer | 2025 | 40877840 | PubTator, text mining | PubMed |
| Established Cancer Predisposition Genes in Single and Multiple Cancer Diagnoses. | JAMA Oncol | 2025 | 40875208 | PubTator, text mining | PubMed |
| Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review). | Mol Med Rep | 2025 | 40849815 | PubTator, text mining | PubMed |
| Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women. | Nat Commun | 2025 | 40841357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=6